Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

v3.8.0.1
Subsequent Events (Details Narrative)
3 Months Ended 12 Months Ended
Mar. 06, 2018
shares
Mar. 05, 2018
USD ($)
Feb. 15, 2018
USD ($)
$ / shares
Feb. 14, 2018
shares
Feb. 09, 2018
USD ($)
shares
Sep. 21, 2017
Feb. 07, 2017
shares
Jul. 19, 2016
USD ($)
Nov. 02, 2015
Apr. 01, 2018
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Apr. 18, 2018
$ / shares
shares
Jan. 31, 2018
a
ft²
$ / shares
Oct. 30, 2017
USD ($)
Oct. 05, 2017
$ / shares
Feb. 22, 2017
$ / shares
Dec. 31, 2016
$ / shares
shares
Debt instrument maturity date                     May 30, 2018            
Proceeds from offering | $               $ 7,500,000                  
Number of shares issued for debt conversion                     18,285,517            
Common stock par value | $ / shares                     $ 0.01       $ 0.01 $ 0.01 $ 0.01
Reverse stock split of outstanding common shares           1-for-15 reverse stock split effective October 5, 2017 1-for-30 reverse stock split of the Company’s shares of common stock effective on February 22, 2017   1-for-10 reverse stock split                
Common stock shares authorized             500,000,000       500,000,000           500,000,000
Subsequent Event [Member]                                  
Number of shares issued for debt conversion                   480,249,156              
Common stock par value | $ / shares                       $ 0.01          
Common stock shares authorized                       3,000,000,000          
Subsequent Event [Member] | May 30, 2018 [Member]                                  
Proceeds from fee received | $                     $ 100,000            
Due to purchaser | $                     $ 100,000            
Subsequent Event [Member] | May 2, 2018 [Member] | 2018 Incentive Award Plan [Member]                                  
Number of common shares available for grant                     100,000,000            
Subsequent Event [Member] | May 2, 2018 [Member] | Previously Authorized [Member]                                  
Common stock shares authorized                     500,000,000            
Subsequent Event [Member] | May 2, 2018 [Member] | Maximum [Member]                                  
Reverse stock split of outstanding common shares                     1-for-50            
Subsequent Event [Member] | May 2, 2018 [Member] | Minimum [Member]                                  
Reverse stock split of outstanding common shares                     1-for-300            
Subsequent Event [Member] | Series I-2 Preferred Stock [Member]                                  
Number of shares issued for debt conversion         1,731                        
Subsequent Event [Member] | Additional Debentures [Member]                                  
Debt instrument face amount | $   $ 2,480,000                              
Debt instrument maturity date   Sep. 19, 2019                              
Proceeds from offering | $   $ 2,000,000                              
Subsequent Event [Member] | September Debentures [Member]                                  
Principal amount of debt converted into shares | $         $ 1,384,556                        
Subsequent Event [Member] | Employees and Directors [Member]                                  
Number of common shares granted as compensation 71,333,331                                
Subsequent Event [Member] | Purchase Agreement [Member]                                  
Purchase price equal to net working capital, amount | $ / shares                         $ 1.00        
Area of land | ft²                         90,000        
Subsequent Event [Member] | Purchase Agreement [Member] | Hospital Building [Member]                                  
Area of land | a                         8        
Subsequent Event [Member] | Stock Purchase Agreement [Member] | Two Investors [Member]                                  
Number of common shares agreed to sell       200,000                          
Sale of stock price per share | $ / shares     $ 4.00                            
Consideration received on sale of stock | $     $ 800,000                            
Subsequent Event [Member] | Exchange Agreement [Member]                                  
Debt instrument face amount | $                           $ 9,016,136